Medicine and Dentistry
Peritonsillar Abscess
72%
Antibiotics
60%
Infection
58%
Immune Response
52%
Retropharyngeal Abscess
48%
Systematic Review
48%
Fusobacterium necrophorum
48%
Severe Acute Respiratory Syndrome Coronavirus 2
48%
COVID-19
48%
Neoplasm
38%
Clinical Trial
37%
Tonsillitis
32%
Incision
32%
General Medicine
30%
Tonsillectomy
30%
Head and Neck Squamous Cell Carcinoma
30%
Pathogen
28%
Prevalence
26%
Penicillin Derivative
25%
General Practitioner
24%
Biological Marker
24%
Targeted Therapy
24%
Lung Cancer
24%
Sore Throat
24%
Krukenberg Tumor
24%
Acute Otitis Media
24%
DNA A
24%
Poly ADP Ribose Polymerase
24%
Vascular Ring
24%
Patient Characteristics
24%
Observational Study
24%
Trachea Stenosis
24%
Wart Virus
24%
Molecularly Targeted Therapy
24%
Methylation
24%
Mitogen-Activated Protein Kinase
24%
Antiviral Therapy
24%
Virus Cell Interaction
24%
Disease Course
24%
Adaptive Response
24%
Nasal Cavity
24%
Homeobox
24%
Fibroblast Growth Factor Receptor 1
24%
Knee Osteoarthritis
24%
Mesenchymal Stem Cell
24%
Randomized Clinical Trial
20%
Circulating Tumor DNA
18%
Abscess
17%
Recurrent Disease
13%
Intensive Care
12%
Immunology and Microbiology
Nose
100%
Abscess
72%
Fusobacterium necrophorum
67%
Infectious Agent
60%
Immune Response
52%
Microbiology
48%
Severe Acute Respiratory Syndrome Coronavirus 2
48%
COVID-19
48%
Neck
32%
Tonsillitis
27%
Prevalence
26%
Hib Vaccine
24%
Methylation
24%
Squamous Cell
24%
Pharyngitis
24%
Vaccination Policy
24%
Wart Virus
24%
Homeobox
24%
Virus Cell Interaction
24%
Necrotizing Fasciitis
24%
Osteoarthritis
24%
Mesenchymal Stem Cell
24%
Knee
24%
Prevotella
20%
Streptococcus anginosus
20%
Streptococcus pyogenes
17%
Epstein Barr Virus
10%
Anaerobe
10%
Progression Free Survival
9%
Overall Survival
9%
Streptococcus Group A
8%
Staphylococcus Aureus
8%
Oropharynx
8%
Hemolytic Streptococcus
6%
Tonsil
6%
Microorganism
6%
Adenoviridae
6%
Surface Property
6%
Palatine Tonsil
6%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
48%
Fusobacterium necrophorum
38%
Peritonsillar Abscess
36%
Antibiotic Agent
33%
Antibiotics
30%
Prevalence
28%
Tonsillitis
26%
Fibroblast Growth Factor Receptor 1
26%
Acute Epiglottitis
24%
Retropharyngeal Abscess
24%
Lung Cancer
24%
Anaplastic Thyroid Carcinoma
24%
Ear Infection
24%
Nose Infection
24%
Pharyngitis
24%
Observational Study
24%
Knee Osteoarthritis
24%
Abscess
20%
Penicillin Derivative
19%
Infection
16%
Protein Tyrosine Kinase
16%
Osteoarthritis
16%
Cefuroxime
9%
Recurrent Disease
9%
Malignant Neoplasm
8%
Phosphotransferase Inhibitor
8%
Fibroblast Growth Factor Receptor 3
8%
Multiple Cancer
8%
Bile Duct Carcinoma
8%
Long Term Exposure
8%
Bladder Cancer
8%
Neurotrophin Receptor
8%
Head and Neck Squamous Cell Carcinoma
8%
Cell Culture
8%
Disease Exacerbation
8%
Hyaluronic Acid
8%
Human Study
8%
Arthropathy
8%
Diseases
8%
Infectious Agent
7%
Antibiotic Therapy
6%
Fibroblast Growth Factor Receptor 4
6%
Streptococcus Group A
6%
Staphylococcus Aureus
6%
Tonsil Carcinoma
6%
